Literature DB >> 10211095

The risk of breast cancer following reproductive surgery.

N Kreiger1, M Sloan, M Cotterchio, V Kirsh.   

Abstract

Alteration of exposure to ovarian hormones, by eliminating or impairing the function of one or both ovaries, may affect the risk of breast cancer. To assess the relationship between reproductive surgical procedures and breast cancer risk, we conducted a retrospective cohort study involving 524,709 Ontario women who underwent tubal ligation or other salpingectomy, hysterectomy and/or ovariectomy between 1979 and 1993. Data on type and year of surgery were obtained from hospital records and linked with breast cancer diagnoses recorded in the Ontario Cancer Registry. Observed breast cancers were compared with age- and calendar-period expected rates in Ontario. A decreased risk of breast cancer was observed among women who had undergone either hysterectomy (observed/expected [O/E] = 0.87, P < 0.001) or unilateral ovariectomy (O/E = 0.74, P < 0.001). Bilateral ovariectomy and tubal ligation were associated with reduced risk when the surgery occurred before the age of 45 years, and tubal ligation was protective if performed after the age of 54 years. There was no trend in risk with increasing follow-up. Our data support the hypothesis that reduced levels of endogenous oestrogen may be protective for breast cancer in women.

Entities:  

Mesh:

Year:  1999        PMID: 10211095     DOI: 10.1016/s0959-8049(98)00343-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  14 in total

1.  Invited commentary: reproductive organ surgeries and breast cancer risk--apples, oranges, or fruit cocktail?

Authors:  David J Press; Leslie Bernstein
Journal:  Am J Epidemiol       Date:  2013-02-14       Impact factor: 4.897

2.  Long term effects of hysterectomy on mortality: nested cohort study.

Authors:  Lisa Iversen; Philip C Hannaford; Alison M Elliott; Amanda J Lee
Journal:  BMJ       Date:  2005-06-01

3.  The relationship between bilateral oophorectomy and plasma hormone levels in postmenopausal women.

Authors:  Joanne Kotsopoulos; Amy L Shafrir; Megan Rice; Susan E Hankinson; A Heather Eliassen; Shelley S Tworoger; Steven A Narod
Journal:  Horm Cancer       Date:  2014-12-19       Impact factor: 3.869

4.  Bilateral oophorectomy and risk of cancer in African American women.

Authors:  Deborah A Boggs; Julie R Palmer; Lynn Rosenberg
Journal:  Cancer Causes Control       Date:  2014-02-01       Impact factor: 2.506

Review 5.  Understanding breast cancer risk -- where do we stand in 2005?

Authors:  R G Dumitrescu; I Cotarla
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

6.  Breast cancer risk and ovariectomy, hysterectomy, and tubal sterilization in the women's contraceptive and reproductive experiences study.

Authors:  David J Press; Jane Sullivan-Halley; Giske Ursin; Dennis Deapen; Jill A McDonald; Brian L Strom; Sandra A Norman; Michael S Simon; Polly A Marchbanks; Suzanne G Folger; Jonathan M Liff; Ronald T Burkman; Kathleen E Malone; Linda K Weiss; Robert Spirtas; Leslie Bernstein
Journal:  Am J Epidemiol       Date:  2010-11-25       Impact factor: 4.897

7.  Tubal ligation and the risk of vertebral fractures.

Authors:  Grace Wyshak
Journal:  Osteoporos Int       Date:  2004-09-29       Impact factor: 4.507

8.  Postoophorectomy estrogen use and breast cancer risk.

Authors:  Hazel B Nichols; Amy Trentham-Dietz; Polly A Newcomb; Linda J Titus; Kathleen M Egan; John M Hampton; Kala Visvanathan
Journal:  Obstet Gynecol       Date:  2012-07       Impact factor: 7.661

9.  Breast cancer risk and hysterectomy status: the Multiethnic Cohort study.

Authors:  Christy G Woolcott; Gertraud Maskarinec; Malcolm C Pike; Brian E Henderson; Lynne R Wilkens; Laurence N Kolonel
Journal:  Cancer Causes Control       Date:  2008-11-14       Impact factor: 2.506

Review 10.  Environmental pollutants and breast cancer.

Authors:  Julia Green Brody; Ruthann A Rudel
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.